Excretion in urine of o-hydroxyphenylacetic acid (0-OH-PAA) was measured quantitatively during a 24-hr period in 43 children ranging from 2 weeks to 12 years of age who were affected by different types of hyperphenylalaninemia (20 typical phenylketonuria (PKU) 7 atypical PKU, and 16 mild forms according to the classification of Auerbach et 01.); 28 out of the 33 cases diagnosed at birth in the course of a screening program were examined before reaching 3 months of age. Phenylpyruvic acid (PPA) excretion was estimated at the same time semiquantitatively.
Introduction
fecting either phenylalanine hydroxylation or transaBecause no simple enzymatic techniques are available, mination is based on several biochemical criteria and the method used to distinguish between defects afespecially on the presence or absence of o-OH-PAA and PPA in the urine of patients [8, 221 . These metabolites are, of course, normally found in urine with levels of phenylalanine in plasma greater than 0.4 pmol/ml (7 mg/100 ml) for the former and 0.9 pmol/ ml (15 mg/100 ml) for the latter, their catabolism being, below these values, faster than their synthesis [3, 6, 161 . However, the influence of age on their excretion has as yet never been analyzed systematically in children under 2 years of age. This fact prompted us to undertake this study in 28 children affected by classic and so-called "Mediterranean" PKU as well as by mild hyperphenylalaninemia detected at birth by submitting them to oral or intravenous phenylalanine loads. By analyzing the results obtained at different ages and those recorded in older patients (mentally retarded or not), it was found that the transaminase system is not mature until 2 years of age, making it impossible to use the presence or absence of phenylalanine metabolites in urine to determine, at the time of birth, which enzymatic step is being affected.
Forty-three children (23 boys and 20 girls), who ranged in age from 2 weeks to 12 years, were studied. Thirtythree cases were detected at birth, 17 in our laboratory, and 16 by the Evian Screening Center; the remaining 10 were recognized at older ages, either because of mental retardation or in the course of familial investigations. They were classified, according to the terminology of Auerbach et al. [8] , as a function of the level of phenylalanine in their plasma at the time of the diagnosis, as they were fed a diet containing 3 g protein/kg body wt; under these conditions, 20 were considered as affected by typical PKU, 7 by atypical PKU, and 16 by mild hyperphenylalaninernia. Daily excretion of PPA and o-OH-PAA in urine was measured in every case at the time of the initial diagnosis except for three typical and two atypical PKU cases detected at birth in whom o-OH-PAA determination was not made until 1 or 2 years of age. T h e same measures were repeated as hyperphenylalaninemia decreased to normal values after the onset of the treatment in those who were submitted to a restricted diet. They were measured again at the ages of 6 months, 1 year, or 2 years; for this purpose, during a 4-to 6-day period, they were fed a diet containing the equivalent in phenylalanine of 3 g proteinlkg body wt. Moreover, the excretion of these metabolites in urine was studied in 16 cases (10 typical or atypical PKU and 6 mild forms) after an intravenous perfusion of 0.06 M Lphenylalanine (500 ml/m2 in 3 hr); the level of phenylalanine in plasma was thus raised to 2.5-3.0 pmol/ ml; urine samples were collected during the first 6 hr and then every 12 hr until phenylalaninemia was returned to initial values; o-OH-PAA excretion was plotted against the logarithmic mean of phenylalanine in plasma for each time interval.
Phenylalanine in plasma was measured at p H 4.3 by column chromatography [24] with a single 0.2 N Na+ citrate buffer [23] or on microsamples (10 pl) by automatic fluorometry [24] according to the technique of Hill et al. [14] . Assay of o-OH-PAA was made quantitatively by the technique of Armstrong et al. [5] , modified as follows: descending chromatography was performed in one dimension on Whatman no. 1 filter paper with isopropyl alcohol-aqueous ammonia-H,O (201 112); diazotized p-nitroaniline was sprayed to visualize the phenolic compounds; after elution of the o-OH-PAA spot, OD was read at 530 nm. Concentrations of 0.01 PM can be detected safely by this method [13] . Excretion of PPA was estimated from trace to very positive levels (++) by ferric chloride tests, DPNH+ reactions, and Phenistix; the enol-borate technique was used in a few cases.
PPA and o-OH-PAA Excretion in Children under 3

Months of Age
In children under 3 months of age, at the time of the first admission to the metabolic ward, there is practically no excretion of PPA (<0.5 m~/ l i t e r as controlled by the enol-borate method) as long as the level of phenylalanine in plasma is below 1.5 pmol/ ml; above this value, ferric chloride tests are always positive (traces or +) but never ++, even if phenylalaninemia exceeds 3.0 q o l / m l . Whatever the type of hyperphenylalaninernia, o-OH-PAA excretion remains very low also (<5 p~/ 2 4 hr) until the level of phenylalanine in plasma exceeds 1.5 pmol/ml; it then increases proportionally to the blood level, being, on the average, 10 PM for phenylalanine levels ranging from 1.5 to 2.1, 15 p~ from 2.1 to 2.7, and 20 , L L M /~~ hr over 2.7 pmol/ml (Fig. 1) . At that age, therefore, with a protein intake of 3 4 g/kg body wt, ferric chloride tests and o-OH-PAA excretion are positive in typical and atypical PKU only; in mild hyperphenylalaninemia, where, by definition, the level of phenylalanine in plasma is below 1.5 pmol/ml whatever the protein intake, results are always negative (Table I) . 
Variations with Age of PPA and o-OH-PAA Excretion
T h e concentration of PPA in urine becomes progressively greater as the patients get older; values above 2.5 m~/ l i t e r (++) are observed at 1 year of age for phenylalaninemia exceeding 1.8 pmol/ml and at 2 years of age for phenylalaninemia exceeding 1.2 pmol/ ml; the threshold for PPA excretion decreases after 2 years of age to 0.7 or 0.8 pmol/ml. Excretion of o-OH-PAA increases in the same way; it is significantly higher at 6 months than it is during the neonatal period (P < 0.001), higher at 1 year than at 6 months, and higher at 2 years than at 1 (Figs. 1 and 2) ; the figures obtained in the oldest ~o u p for the class interval (0.4-0.9 ,,,mol/ml) are identical with those recorded . .
in the youngest group for the highest plasma levels (Table 11) .
Comparison between PKU and Mild Fornzs after Intravenous Perfusion
Excretion of PPA increases with age in this condition also; ferric chloride tests are, in fact, always positive after the age of 2 years for the highest plasma levels (2.4-3.0 pmol/ml) in the mild forms as in typical and atypical PKU (pooled in Tables I11 and IV because of the small number of patients). Taking age into account, o-OH-PAA is also similar if not higher in some mild form cases than in PKU.
Discussion
I n spite of some contradictory statements [I, 21, it is now established firmly that the screening for PKU must be done during the first days of life by measurement of phenylalaninemia and not of its primary metabolites in urine i.e., PPA and o-OH-PAA [lo, 181.
Unquestionable observations of typical as well as atypical PKU for which a transient transamination defect had been suspected because of the negativity of the urine tests for several weeks have, in fact, been published [4, 8, 151. Isolated phenylalanine transaminase deficiencies were also postulated by Auerbach in 1965 [7] , and several observations were later attributed to age, 2, 10, a n d 40 times higher a t 6 m o n t h s , 1 year, and 2 years, respectively, t h a n before 2 m o n t h s of age; (4) t h a t t h e excretion thresholds of 0.4-0.5 p m o l / m l (7 t o 8 m g ) f o r o-OH-PAA [3, 9, 111 a n d of 0.6-0.9 pmol/ml (10-15 m g / 1 0 0 m l ) f o r PPA [6, 91 are r e a c h e d only after t h e a g e of 2 years. T h i s e x p l a i n s why, a t t h e first e x a m i n a t i o n , t h e patients w i t h p h e n y l a l a n i n e m i a beiow 1.5 p m o l / m l c a n be considered as affected by a t r a n s a m i n a t i o n defect a n d w h y those presenting h i g h e r p l a s m a levels a n d excreting e n o u g h PPA t o show a positive ferric c h l o r i d e test a r e considered immediately t o be deficient in p h e n y l a l a n i n e hydroxylase.
The fact t h a t b o t h PPA a n d o-OH-PAA excretions a r e r e d u c e d suggests strongly a delayed m a t u r a t i o n of p h e n y l a l a n i n e transaminase, even in t h e absence of its direct assay in c r u d e liver homogenates; s u c h a n assay w o u l d , f u r t h e r m o r e , b e difficult t o i n t e r p r e t because tyrosine-a-ketoglutarate transaminase, already active a t b i r t h [19, 201 , also h a s s o m e affinity f o r p h e n y l a l a n i n e [17] . T h i s p r o b a b l e delayed m a t u r a t i o n c o u l d a c c o u n t i n p a r t , w i t h t h e relative r e d u c t i o n in p r o t e i n i n t a k e [21] , for t h e decrease of p h e n y l a l a n i n e m i a as c h i l d r e n g r o w older.
Finally, perfusion d a t a s h o w t h a t n o significant dist i n c t i o n c a n b e m a d e l a t e r i n PPA a n d o-OH-PAA excretions between PKU a n d m i l d forms, insofar as p h e n y l a l a n i n e m i a is raised t o a sufficiently h i g h level. T h i s definitely eliminates, i n cases s t u d i e d b y this techn i q u e , t h e hypothesis of a p e r m a n e n t t r a n s a m i n a t i o n defect, a l t h o u g h t h e possibility of s u c h a m u t a t i o n c a n n o t b e r u l e d o u t i n o t h e r cases.
Quantitative studies of excretion of o-OH-PAA in u ri n e show t h a t i t is d e p e n d e n t o n b o t h t h e a g e of t h e c h i l d ( u n d e r 2 years of age) a n d t h e level of phenylalan i n e i n plasma. In this regard, n o distinction c a n b e m a d e between PKU a n d its genetic variants.
